TITLE

Glycemic Control in the Intensive Care Unit: Why We Should Wait for NICE-SUGAR

AUTHOR(S)
Bellomo, Rinaldo; Egi, Moritoki
PUB. DATE
December 2005
SOURCE
Mayo Clinic Proceedings;Dec2005, Vol. 80 Issue 12, p1546
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article focuses on the importance of glycemic control in critical care medicine. One research claimed that intensive insulin therapy to maintain blood glucose reduces morbidity and mortality among critically ill patients in the surgical intensive care unit. Studies in diabetic patients suggest that better glucose control may yield benefits in terms of morbidity or mortality in nondiabetic critically ill patients. However, intensive insulin therapy comes at a substantial price.
ACCESSION #
19168644

 

Related Articles

  • EB67 Evidence-Based Glucose Target Range for Insulin Infusions in Critical Care.  // Critical Care Nurse;Apr2012, Vol. 32 Issue 2, pe39 

    An abstract of the article "Evidence-Based Glucose Target Range for Insulin Infusions in Critical Care," by Tamara Coker and Kimberly Roberts is presented.

  • Intensive insulin therapy in the ICU. Van den Berghe, Greet // Indian Journal of Critical Care Medicine;Apr-Jun2003, Vol. 7 Issue 2, p106 

    The risk of mortality or significant morbidity is high among critically ill patients who are treated in the intensive care unit (ICU) for more than 5 days. These patients are susceptible to sepsis, excessive inflammation, critical illness polyneuropathy and multiple organ failure, the latter...

  • Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Griesdale, Donald E. G.; de Souza, Russell J.; van Dam, Rob M.; Heyland, Daren K.; Cook, Deborah J.; Malhotra, Atul; Dhaliwal, Rupinder; Henderson, William R.; Chittock, Dean R.; Finfer, Simon; Talmor, Daniel // CMAJ: Canadian Medical Association Journal;4/14/2009, Vol. 180 Issue 8, p821 

    Background: Hyperglycemia is associated with increased mortality in critically ill patients. Randomized trials of intensive insulin therapy have reported inconsistent effects on mortality and increased rates of severe hypoglycemia. We conducted a meta-analysis to update the totality of evidence...

  • Evaluation of lacrimal fluid as an alternative for monitoring glucose in critically ill patients. LeBlanc, Jaclyn; Haas, Curtis; Vicente, Glorimar; Colon, Luis // Intensive Care Medicine;Oct2005, Vol. 31 Issue 10, p1442 

    Objective: This study evaluated the use of lacrimal fluid glucose concentrations as a minimally invasive, alternative sampling strategy for monitoring glucose concentrations in surgical/trauma ICU patients. Design and setting: Prospective, paired sample study in an adult surgical/trauma ICU....

  • The responsibility of undertaking large randomized controlled trials. Preiser, Jean-Charles; Wernerman, Jan // Intensive Care Medicine;Feb2014, Vol. 40 Issue 2, p266 

    The authors discuss research on glucose monitoring and glucose control in critically ill patients. They reference the study "Tight Computerized Versus Conventional Glucose Control in the ICU: A Randomized Controlled Study" by P. Kalfon and colleagues published in the current issue of the...

  • Safe Utilization of Hyperglycemia Management in the ICU. Loh-Trivedi, Mira; Croley, W. Christopher // Current Drug Safety;Jan2010, Vol. 5 Issue 1, p19 

    Critically ill patients admitted to intensive care units (ICUs) often present with multiple medical or surgical problems requiring a high level of care. In addition to a patient's underlying illness, a number of known risk factors can predispose patients to episodes of hyperglycemia as well as...

  • Stress hyperglycaemia in critically ill patients; Potential role of incretin hormones; a preliminary study. Llompart-Pou, J. A.; Fernández-de-Castillo2, A. G.; Burguera, B.; Pérez-Bárcena, J.; Marsé, P.; Rodríguez-Yago, M.; Barcelo, A.; Raurich, J. M. // Nutricion Hospitalaria;ene/feb2012, Vol. 27 Issue 1, p130 

    Background: Stress hyperglycaemia is common in the intensive care unit (ICU) setting and has been related to a worst outcome. Objective: The objective was to characterize the association of glucoregulatory hormones, mainly incretins, with the levels of glycaemia, and its relationship with...

  • Decision support for optimized blood glucose control and nutrition in a neurotrauma intensive care unit: preliminary results of clinical advice and prediction accuracy of the Glucosafe system. Pielmeier, Ulrike; Rousing, Mark; Andreassen, Steen; Nielsen, Birgitte; Haure, Pernille // Journal of Clinical Monitoring & Computing;Aug2012, Vol. 26 Issue 4, p319 

    Assessment of glycemic control with model-based decision support ('Glucosafe') in neurotrauma intensive care patients in an ongoing randomized controlled trial with a blood glucose (BG) target of 5-8 mmol/L. Assessment of BG prediction accuracy of the model and assessment of the effect that two...

  • The metrics of glycaemic control in critical care. Mackenzie, Iain M. J.; Whitehouse, Tony; Nightingale, Peter G. // Intensive Care Medicine;Mar2011, Vol. 37 Issue 3, p435 

    Introduction: Trials of tight glucose control have compared measures of central tendency, such as average blood glucose, and yielded conflicting results. Other metrics, such as standard deviation, reflect different properties of glucose control and are also associated with changes in outcome. It...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics